Advertisement

PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL

Peter Dreger, Anna Sureda, Kwang Woo Ahn, Mary Eapen, Carlos Litovich, Herve Finel, Ariane Boumendil, Ajay Gopal, Alex F. Herrera, Christoph Schmid, José Luis Diez-Martin, Ephraim Fuchs, Javier Bolaños-Meade, Mahasweta Gooptu, Monzr M. Al Malki, Luca Castagna, Stefan O. Ciurea, Alida Dominietto, Didier Blaise, Fabio Ciceri, Johanna Tischer, Paolo Corradini, Silvia Montoto, Stephen Robinson, Zafer Gülbas and Mehdi Hamadani

Article Information

Citation 
vol. 3 no. 3 360-369
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted October 26, 2018
  • Accepted January 2, 2019
  • Published online February 5, 2019.


Contributors 
  • Peter Dreger, 1Department Medicine V, University of Heidelberg, Heidelberg, Germany;
  • Anna Sureda, 2Hematology Department, Institut Català d'Oncologia–Hospitalet, Barcelona, Spain;
  • Kwang Woo Ahn, 3Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI;4Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI;
  • Mary Eapen, 4Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI;
  • Carlos Litovich, 4Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI;
  • Herve Finel, 5European Society for Blood and Marrow Transplantation, Paris, France;
  • Ariane Boumendil, 5European Society for Blood and Marrow Transplantation, Paris, France;
  • Ajay Gopal, 6Division of Medical Oncology, Clinical Research Division, Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, WA;
  • Alex F. Herrera, 7City of Hope, Duarte, CA;
  • Christoph Schmid, 8Klinikum Augsburg, Augsburg, Germany;
  • José Luis Diez-Martin, 9Hospital Gregorio Marañón, Madrid, Spain;
  • Ephraim Fuchs, 10Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD;
  • Javier Bolaños-Meade, 10Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD;
  • Mahasweta Gooptu, 11Dana-Farber Cancer Institute, Boston, MA;
  • Monzr M. Al Malki, 7City of Hope, Duarte, CA;
  • Luca Castagna, 12Istituto Clinico Humanitas, Rozzano Milan, Italy;
  • Stefan O. Ciurea, 13University of Texas, MD Anderson Cancer Center, Houston, TX;
  • Alida Dominietto, 14Divisione Ematologia e Trapianto di Midollo, Istituto di Ricovero e Cura a Carattere Scientifico San Martino, Genoa, Italy;
  • Didier Blaise, 15Programme de Transplantation and Thérapie Cellulaire–Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France;
  • Fabio Ciceri, 16Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy;
  • Johanna Tischer, 17Department of Internal Medicine III, Campus Großhadern, University of Munich, Munich, Germany;
  • Paolo Corradini, 18Department of Oncology and Hematology, University of Milan, Milan, Italy;
  • Silvia Montoto, 5European Society for Blood and Marrow Transplantation, Paris, France;19Department of Haemato-oncology, St Bartholomew’s Hospital, Barts Health NHS Trust, London, United Kingdom;
  • Stephen Robinson, 5European Society for Blood and Marrow Transplantation, Paris, France;20BMT Unit, University Hospital Bristol NHS Foundation Trust, Bristol, United Kingdom; and
  • Zafer Gülbas, 21Anadolu Medical Center Hospital, Kocaeli, Turkey
  • Mehdi Hamadani, 4Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output